Skip to content

Effectiveness of patient report outcome system (ii-nave) for breast cancer patients during hormone therapy

Effectiveness of patient report outcome system (ii-nave) for breast cancer patients during hormone therapy - ii-navi resarch

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033347
Enrollment
150
Registered
2018-08-01
Start date
2018-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Use ii-navi usual care

Sponsors

Saitama Prefectural University
Lead Sponsor
St Luke&#39
Collaborator
s International Hospital
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: taking tamoxifen treatment

Exclusion criteria

Exclusion criteria: recurrence/metastasis mental illness severe anxiety/depression

Design outcomes

Primary

MeasureTime frame
check sheet of breast cancer patient receiveing hormone therapy

Secondary

MeasureTime frame
QOL:FACT-B Anxiety, Depression:HADS satisfaction of medical service:VAS

Countries

Japan

Contacts

Public ContactYUKIKO IIOKA

Saitama Prefectural University Graduate course of Health and Social Services

iioka-yukiko@spu.ac.jp048-973-4168

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026